Firefly Neuroscience, Inc. (AIFF) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 1.19 |
| Open | 1.71 |
| Day High | 1.77 |
| Day Low | 1.48 |
| 52-Week High | 3.15 |
| 52-Week Low | 0.62 |
| Volume | 85.84M |
| Average Volume | 317,177 |
| Market Cap | 23M |
| PE | -2.78 |
| EPS | -0.56 |
| Moving Average 50 Days | 1.11 |
| Moving Average 200 Days | 1.37 |
| Change | 0.37 |
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
Newsfile
Mar 06, 2025 12:30 PM GMT
A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementiaCalgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: